KING PHARMACEUTICALS INC

Research KING PHARMACEUTICALS INC (KG) on Bullrun: market cap USD 58.76M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 58.76M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 34.05MUSD 46.73M-USD 96.14Mn/a8.08USD 15.48MUSD 174.40MUSD 128.28M
FY2024USD 3.85M-USD 1.29Mn/an/a-0.47USD 4.29MUSD 0USD 4.61M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 58.76Mn/an/an/a
20252025-12-31USD 79.28M1.0n/an/a
20232023-12-29n/a9.7n/an/a
20222022-12-30n/a5.2n/an/a
20212021-12-31n/a2.3n/an/a

About KING PHARMACEUTICALS INC

Kestrel Group Ltd engages in the reinsurance business. It operates through two segments: Program Services and Legacy Reinsurance. The company offers fronting services to insurance program managers, managing general agencies, reinsurers, and reinsurance brokers in Bermuda. The company is based in Hamilton, Bermuda.

Related stock research

Other Financial Services stocks

Frequently asked questions

What is KING PHARMACEUTICALS INC's market cap?

KING PHARMACEUTICALS INC's market capitalization is USD 58.76M.

What does KING PHARMACEUTICALS INC do?

Kestrel Group Ltd engages in the reinsurance business. It operates through two segments: Program Services and Legacy Reinsurance. The company offers fronting services to insurance program managers, managing general agencies, reinsurers, and reinsurance brokers in Bermuda. The company is based in Hamilton, Bermuda.